STOCK TITAN

Zynex Earns Prestigious 2024 Top Workplaces USA Employer Recognition Award

Rhea-AI Impact
(No impact)
Rhea-AI Sentiment
(Very Positive)
Tags
Rhea-AI Summary
Zynex, Inc. (NASDAQ: ZYXI) has been awarded the prestigious 2024 Top Workplaces USA award, highlighting their commitment to a people-first workplace culture. The company's dedication to excellence and collaboration has led to this national recognition, showcasing their exceptional workplace environment.
Positive
  • None.
Negative
  • None.

ENGLEWOOD, Colo., April 2, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced it is a recipient of the prestigious 2024 Top Workplaces USA award, featured in USA TODAY. This achievement underscores the organization's dedication to fostering a people-first workplace culture and prioritizing the employee experience.

"Being recognized as a 2024 Top Workplace is a testament to the dedication and passion of our team. Their unwavering commitment to excellence and collaborative spirit are the driving forces behind our success. This accolade reaffirms our belief that fostering a positive and supportive work environment is essential for both individual growth and organizational achievement." - Thomas Sandgaard, Founder, Chairman, and CEO.

With a history spanning 17 years, the Top Workplaces program has surveyed over 27 million employees, spotlighting culture excellence across 60 regional markets. The Top Workplaces USA designation honors the nation's employers of choice.

The national recognition celebrates organizations with 150 or more employees cultivating exceptional workplace environments. Of the more than 42,000 invited organizations, Zynex secured the award based solely on an employee engagement survey administered by Energage, the HR technology and research firm behind the Top Workplaces program. Survey results were evaluated by comparing responses to research-based statements that predict high performance against industry benchmarks.

Eric Rubino, Energage CEO, commented, "The Top Workplaces award is a badge of honor and something companies should be very proud to showcase. The people-first cultures they have built and nurtured will set them apart in a highly competitive market. These organizations represent the best of the best."

About Zynex

Zynex, founded in 1996, develops, manufactures, markets, and sells medical devices used for pain management and rehabilitation as well as non-invasive fluid, sepsis, and laser-based pulse oximetry monitoring systems for use in hospitals. For additional information, please visit: www.zynex.com.

Investor Relations Contact:
Quinn Callanan, CFA or Brian Prenoveau, CFA
MZ Group – MZ North America
ZYXI@mzgroup.us
+949 694 9594

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/zynex-earns-prestigious-2024-top-workplaces-usa-employer-recognition-award-302105653.html

SOURCE Zynex

Zynex, Inc. received the prestigious 2024 Top Workplaces USA award.

The Top Workplaces program focuses on surveying employees to highlight culture excellence.

The employee engagement survey for the Top Workplaces program is administered by Energage.

Organizations need to have 150 or more employees to qualify for the Top Workplaces USA designation.

Survey results were evaluated by comparing responses to research-based statements that predict high performance against industry benchmarks.
ZYNEX INC

NASDAQ:ZYXI

ZYXI Rankings

ZYXI Latest News

ZYXI Stock Data

365.59M
15.72M
51.14%
31.25%
18%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
ENGLEWOOD

About ZYXI

zynex, inc. founded in 1996, engineers, manufactures and markets neuro-diagnostics, stroke rehabilitation, pain management and cardiac monitoring devices within three subsidiaries. zynex medical is a provider of electrotherapy products for home use. zynex monitoring solutions develops products for cardiac monitoring for use in hospitals. zynex neurodiagnostics develops devices for emg and eeg diagnostic applications within neurology disciplines. zynex medical's product line is fully developed, fda/ce cleared, commercially sold, and has been developed to uphold the company's mission of improving the quality of life for patients suffering from impaired mobility due to stroke, spinal cord injury, or debilitating and chronic pain. zynex monitoring solutions and zynex neurodiagnostics are currently both in the development stages without any significant revenues.